Return to study ST002976 main page

Download data matrix(Metabolomics Insights into Doxorubicin and 5-Fluorouracil Combination Therapy in Triple-Negative Breast Cancer: A Xenograft Model Study (Part 2) Reversed phase POSITIVE ION MODE)

AnalysisSamplesFactorsUnits
Reversed phase POSITIVE ION MODE2A1-01-10477Treatment:5-fluorouracilAU
Reversed phase POSITIVE ION MODE2A1-02-10478Treatment:5-fluorouracilAU
Reversed phase POSITIVE ION MODE2A2-01-10479Treatment:5-fluorouracilAU
Reversed phase POSITIVE ION MODE2A2-02-10480Treatment:5-fluorouracilAU
Reversed phase POSITIVE ION MODE2B1-01-10481Treatment:5-fluorouracilAU
Reversed phase POSITIVE ION MODE2B1-02-10482Treatment:5-fluorouracilAU
Reversed phase POSITIVE ION MODE2B2-01-10483Treatment:5-fluorouracilAU
Reversed phase POSITIVE ION MODE2B2-02-10484Treatment:5-fluorouracilAU
Reversed phase POSITIVE ION MODE2B3-01-10485Treatment:5-fluorouracilAU
Reversed phase POSITIVE ION MODE2B3-02-10486Treatment:5-fluorouracilAU
Reversed phase POSITIVE ION MODE1A1-01-10464Treatment:DoxorubicinAU
Reversed phase POSITIVE ION MODE1A1-02-10465Treatment:DoxorubicinAU
Reversed phase POSITIVE ION MODE1A2-01-10466Treatment:DoxorubicinAU
Reversed phase POSITIVE ION MODE1A2-02-10467Treatment:DoxorubicinAU
Reversed phase POSITIVE ION MODE1A3-01-10468Treatment:DoxorubicinAU
Reversed phase POSITIVE ION MODE1A3-02-10469Treatment:DoxorubicinAU
Reversed phase POSITIVE ION MODE1B1-01-10470Treatment:DoxorubicinAU
Reversed phase POSITIVE ION MODE1B1-02-10471Treatment:DoxorubicinAU
Reversed phase POSITIVE ION MODE1B2-01-10472Treatment:DoxorubicinAU
Reversed phase POSITIVE ION MODE1B2-02-10473Treatment:DoxorubicinAU
Reversed phase POSITIVE ION MODE1B3-01-10474Treatment:DoxorubicinAU
Reversed phase POSITIVE ION MODE1B3-02-10475Treatment:DoxorubicinAU
Reversed phase POSITIVE ION MODE3A1-01-10488Treatment:Doxorubicin + 5-fluorouracilAU
Reversed phase POSITIVE ION MODE3A1-02-10489Treatment:Doxorubicin + 5-fluorouracilAU
Reversed phase POSITIVE ION MODE3A2-01-10490Treatment:Doxorubicin + 5-fluorouracilAU
Reversed phase POSITIVE ION MODE3A2-02-10491Treatment:Doxorubicin + 5-fluorouracilAU
Reversed phase POSITIVE ION MODE3B1-01-10492Treatment:Doxorubicin + 5-fluorouracilAU
Reversed phase POSITIVE ION MODE3B1-02-10493Treatment:Doxorubicin + 5-fluorouracilAU
Reversed phase POSITIVE ION MODE3B2-01-10494Treatment:Doxorubicin + 5-fluorouracilAU
Reversed phase POSITIVE ION MODE3B2-02-10495Treatment:Doxorubicin + 5-fluorouracilAU
Reversed phase POSITIVE ION MODE3B3-01-10496Treatment:Doxorubicin + 5-fluorouracilAU
Reversed phase POSITIVE ION MODE3B3-02-10497Treatment:Doxorubicin + 5-fluorouracilAU
Reversed phase POSITIVE ION MODE4A1-01-10499Treatment:Positive ControlAU
Reversed phase POSITIVE ION MODE4A1-02-10500Treatment:Positive ControlAU
Reversed phase POSITIVE ION MODE4A2-01-10501Treatment:Positive ControlAU
Reversed phase POSITIVE ION MODE4A2-02-10502Treatment:Positive ControlAU
Reversed phase POSITIVE ION MODE4A4-01-10503Treatment:Positive ControlAU
Reversed phase POSITIVE ION MODE4A4-02-10504Treatment:Positive ControlAU
Reversed phase POSITIVE ION MODE4B1-01-10505Treatment:Positive ControlAU
Reversed phase POSITIVE ION MODE4B1-02-10506Treatment:Positive ControlAU
Reversed phase POSITIVE ION MODE4B2-01-10507Treatment:Positive ControlAU
Reversed phase POSITIVE ION MODE4B2-02-10508Treatment:Positive ControlAU
Reversed phase POSITIVE ION MODE4B3-01-10509Treatment:Positive ControlAU
Reversed phase POSITIVE ION MODE4B3-02-10510Treatment:Positive ControlAU
  logo